Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

4.43
Delayed Data
As of Aug 26
 +0.13 / +3.02%
Today’s Change
1.69
Today|||52-Week Range
5.10
+59.96%
Year-to-Date
No recent news for Opexa Therapeutics Inc.

Today’s Trading

Previous close4.30
Today’s open4.35
Day’s range4.28 - 4.48
Volume31,481
Average volume (3 months)150,325
Market cap$31.2M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+52.55%
Earnings growth (this year)+45.24%
Earnings growth (next 5 years)--
Revenue growth (last year)+100.99%
P/E ratioNM
Price/Sales6.34
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.06-3.61%
HTBXHeat Biologics Inc-0.22-12.79%
PRPHProPhase Labs Inc-0.03-1.33%
CERUCerulean Pharma Inc-0.06-5.41%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$2.6M
Annual profit (last year)-$12.0M
Net profit margin-470.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Neil K. Warma
Chief Scientific Officer
Donald Healey
Corporate headquarters
The Woodlands, Texas

Forecasts

Partner Offers

Search for Jobs